World Stem Cells, LLC. President Dr. Alan A. Kadish gives lecture at the 4th International Congress

Feb. 16, 2012 - PRLog -- Dr. Alan Kadish, president of Worlds Stem cells, LLC will be  giving a lecture at the annual AMMG Age Management Medicine Group which is hosting the 4th International Congress for Regenerative and Cell Based Medicine. Conference scheduled for May 3-6th in Hollywood, Florida. The lecture will focus on findings of stem cell responses secondary to exposure to a range of typical anesthetics and stimulants, used in many overseas and domestic stem cell therapies.  The first part of the lecture addresses a study done secondary to reported cell death, with lidocaine and implications for better therapeutics. The intent is to maximize cell yields and viability with both appropriate timing and choices in products.
The second portion of the lecture series will address the response to stimulation using G-CSF products with a time curve response to optimize the harvesting of stem cells. There is conflicting literature that has divergent times to patient’s results in peripheral mobilization response of White blood cell populations and differential. In our clinical experience we have seen substantially different outcomes, neither age related or per our expectations based on health considerations. Our cohort ranged from those with an autoimmune disorder to normal controls.
The Age Management Group is sponsoring the ICMS International Cellular Medical Society Stem cell conference as part of their anti-aging medical approach to patient care. Pioneering the cutting edge of medicine. These lectures will contribute to the maximization of the stem cell therapies now available at the Advanced Cellular Medicine clinic in Cancun, our contract clinic for World Stem Cells, LLC.
World Stem Cells, LLC through its contact clinic, hospitals and doctors  provides stem cell treatment for a number of diseases focusing on the autoimmune, neurological, orthopedic and ophthalmic disorders. Some of these include: ANKYLOSING SPONDYLITIS, AUTISM, CEREBRAL PALSY,  CHARCOT-MARIE-TOOTH DISEASE (CMT), CROHN’S DISEASES, COPD, FUCH’S DISEASE, GUILLAIN-BARRE’ SYNDROME, HASHIMOTO’S THRYROIDITIS, ITP, KIDNEY DISEASES, MACULAR DEGENERATION, LUPUS (SLE), MULTIPLE SCLEROSIS, PAD, PARKINSON’S DISEASE, RHEUMATOID ARTHRITIS, SCLERODERMA, STROKE, ULCERATIVE COLITIS.
We want to acknowledge the contributions of our laboratory director Dr. Sylvia M. Abblitt and lab manger, Antonio Zamudio Pérez and the staff at Advance Cellular Medicine clinic for their assistance in the evaluation of these critical techniques in the stem cell industry.